UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

C-LIENet: A Multi-Context Low-Light Image Enhancement Network

IEEE access, 2021, Vol.9, p.31053-31064

2021

Volltextzugriff (PDF)

Effect of Freeze–Thaw Cycles on Black Cotton Soil Reinforced with Coir and Hemp Fibres in Alkali-Activated Binder

International journal of geosynthetics and ground engineering, 2020, Vol.6 (2), Article 19

2020

Volltextzugriff (PDF)

Detection of BRCA1 , and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting

Biomedicines, 2022-12, Vol.10 (12), p.3170

2022

Volltextzugriff (PDF)

Strength characterisation of fiber reinforced expansive subgrade soil stabilized with alkali activated binder

Road materials and pavement design, 2022-05, Vol.23 (5), p.1037-1060

2022

Volltextzugriff (PDF)

1350. Limited Opportunities for Student Involvement in Infectious Diseases in the Mountain West: How a New Group is Bridging the Gap

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

On the Variation of Column Density Ratio ΣO/N 2 in the Upper Atmosphere Using Principal Component Analysis in 2‐Dimensional Images

Journal of geophysical research. Space physics, 2023-06, Vol.128 (6)

2023

Volltextzugriff (PDF)

Impact of synchronous (sync) vs metachronous (meta) metastasis at the presentation on survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5049-5049

2023

Volltextzugriff (PDF)

Differential tumor gene expression profiling of obese and non-obese patients (pts) with prostatic adenocarcinoma (PC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5075-5075

2023

Volltextzugriff (PDF)

On the Variation of Column Density Ratio ΣO/N2 in the Upper Atmosphere Using Principal Component Analysis in 2‐Dimensional Images

Journal of geophysical research. Space physics, 2023-06, Vol.128 (6), p.n/a

2023

Volltextzugriff (PDF)

External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer

Molecular cancer therapeutics, 2022-12, Vol.21 (12), p.1857-1861

2022

Volltextzugriff (PDF)

Tumor transcriptomic profiling of patients (pts) with metastatic castration sensitive prostate cancer (mCSPC) who do versus who do not achieve an optimal PSA response to intensiﬁed androgen deprivation therapy (i-ADT)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.234-234

2023

Volltextzugriff (PDF)

Differences in the tumor transcriptomic profile of patients (pts) with advanced prostate cancer (PCa) with and without diabetes mellitus (DM)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.244-244

2023

Volltextzugriff (PDF)

Association of obesity with tumor differential gene expression and gene set enrichment pathways in advanced prostate adenocarcinoma (PCa)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.231-231

2023

Volltextzugriff (PDF)

Correlation of tumor gene expression profile and gleason score (GS) in patients (pts) with metastatic prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.235-235

2023

Volltextzugriff (PDF)

Modelling of hybrid electric vehicle drive train using simulink

Journal of information & optimization sciences, 2022-01, Vol.43 (1), p.213-218

2022

Volltextzugriff (PDF)

Illustration of temporal evolution in patients with metastatic renal cell carcinoma (mRCC) using both circulating tumor DNA (ctDNA) and tissue-based genomic data

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.347-347

2021

Volltextzugriff (PDF)

Transcriptomic profiling of patients (pts) with de-novo metastatic castration-sensitive prostate cancer (DN-mCSPC) versus those with mCSPC that have relapsed from prior localized therapy (PLT-mCSPC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5080-5080

2022

Volltextzugriff (PDF)

Survival outcomes and characterization of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) undergoing intensified androgen deprivation therapy (ADT) who do not achieve an optimal PSA response (PSA ≤0.2 ng/mL)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.123-123

2022

Volltextzugriff (PDF)

Overall survival (OS) after progression on first novel hormonal therapy (NHT) in patients (pts) with metastatic castration-sensitive versus castration-resistant prostate cancer (mCSPC versus mCRPC)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.121-121

2022

Volltextzugriff (PDF)

Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.373-373

2022

Volltextzugriff (PDF)

Progression-free survival (PFS) and overall survival (OS) in patients (pts) with de-novo, high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) undergoing intensified androgen deprivation therapy (ADT)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.133-133

2022

Volltextzugriff (PDF)

A real-time solar powered fire detection system

Journal of information & optimization sciences, 2022-01, Vol.43 (1), p.85-92

2022

Volltextzugriff (PDF)

Response to systemic therapy and survival outcomes in de-novo (D1) metastatic castration-sensitive prostate cancer (mCSPC) versus mCSPC with prior local therapy (D0)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.46-46

2020

Volltextzugriff (PDF)

Genomic correlates of response to PD-1 axis inhibitors (IO) in metastatic urothelial cancer (mUC) using explainable artificial intelligence (AI)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.570-570

2020

Volltextzugriff (PDF)

Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma

Clinical cancer research, 2021-09, Vol.27 (17), p.4807-4813

2021

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Technology
(9)
Life Sciences & Biomedicine
(8)
Computer Science
(4)
Engineering
(4)
Metastatic Prostate Cancer
(4)
Castration
(3)
Humans
(3)
Male
(3)
Metastasis
(3)
Prostate Cancer
(3)
Urology & Nephrology
(3)
Algorithms
(2)
Chemical Treatment
(2)
Computer Architecture
(2)
Computer Science, Artificial Intelligence
(2)
Construction & Building Technology
(2)
Context
(2)
Engineering, Civil
(2)
Feature Extraction
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

C-LIENet: A Multi-Context Low-Light Image Enhancement Network

Effect of Freeze–Thaw Cycles on Black Cotton Soil Reinforced with Coir and Hemp Fibres in Alkali-Activated Binder

Detection of BRCA1 , and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting

Strength characterisation of fiber reinforced expansive subgrade soil stabilized with alkali activated binder

1350. Limited Opportunities for Student Involvement in Infectious Diseases in the Mountain West: How a New Group is Bridging the Gap

On the Variation of Column Density Ratio ΣO/N 2 in the Upper Atmosphere Using Principal Component Analysis in 2‐Dimensional Images

Impact of synchronous (sync) vs metachronous (meta) metastasis at the presentation on survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs)

Differential tumor gene expression profiling of obese and non-obese patients (pts) with prostatic adenocarcinoma (PC)

On the Variation of Column Density Ratio ΣO/N2 in the Upper Atmosphere Using Principal Component Analysis in 2‐Dimensional Images

External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer

Tumor transcriptomic profiling of patients (pts) with metastatic castration sensitive prostate cancer (mCSPC) who do versus who do not achieve an optimal PSA response to intensiﬁed androgen deprivation therapy (i-ADT)

Differences in the tumor transcriptomic profile of patients (pts) with advanced prostate cancer (PCa) with and without diabetes mellitus (DM)

Association of obesity with tumor differential gene expression and gene set enrichment pathways in advanced prostate adenocarcinoma (PCa)

Correlation of tumor gene expression profile and gleason score (GS) in patients (pts) with metastatic prostate cancer

Modelling of hybrid electric vehicle drive train using simulink

Illustration of temporal evolution in patients with metastatic renal cell carcinoma (mRCC) using both circulating tumor DNA (ctDNA) and tissue-based genomic data

Transcriptomic profiling of patients (pts) with de-novo metastatic castration-sensitive prostate cancer (DN-mCSPC) versus those with mCSPC that have relapsed from prior localized therapy (PLT-mCSPC)

Survival outcomes and characterization of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) undergoing intensified androgen deprivation therapy (ADT) who do not achieve an optimal PSA response (PSA ≤0.2 ng/mL)

Overall survival (OS) after progression on first novel hormonal therapy (NHT) in patients (pts) with metastatic castration-sensitive versus castration-resistant prostate cancer (mCSPC versus mCRPC)

Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Progression-free survival (PFS) and overall survival (OS) in patients (pts) with de-novo, high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) undergoing intensified androgen deprivation therapy (ADT)

A real-time solar powered fire detection system

Response to systemic therapy and survival outcomes in de-novo (D1) metastatic castration-sensitive prostate cancer (mCSPC) versus mCSPC with prior local therapy (D0)

Genomic correlates of response to PD-1 axis inhibitors (IO) in metastatic urothelial cancer (mUC) using explainable artificial intelligence (AI)

Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma

Suchergebnisse filtern